Frequently Asked Questions

What Is Peptide Therapy Good For?

Medically Reviewed By: Maura Forte, MSN, FNP-BC
Last Updated: March 11, 2026

The goal of this article is to give you an honest, clinically grounded overview of what peptide therapy is actually good for—what it can do, what the evidence supports, where the science is still emerging, and how it fits into a broader health optimization strategy. If you’re considering peptide therapy or trying to make sense of the landscape, this is the foundation you need.

What You Need to Know

Peptides are short chains of amino acids—typically between 2 and 50 amino acids linked together by peptide bonds. Your body naturally produces thousands of peptides that serve as signaling molecules, hormones, neurotransmitters, and growth factors. They tell your cells what to do: when to grow, when to repair, when to release a hormone, when to mount an immune response, and when to reduce inflammation.

Peptide therapy uses synthetic versions of these naturally occurring signaling molecules to target specific physiological processes. Unlike pharmaceutical drugs that often suppress or override a biological pathway, therapeutic peptides generally work by amplifying or restoring the body’s own signaling—which is why they tend to produce effects that feel natural rather than forced, and why side effect profiles are often favorable when peptides are used responsibly under medical supervision.

Different peptides target different systems. Some stimulate growth hormone release. Others promote tissue repair, modulate immune function, support gut healing, enhance cognitive performance, or improve sleep quality. The specificity of peptides—the fact that each one has a defined biological target—is what makes them so versatile as therapeutic tools. It is also what makes proper clinical guidance essential: choosing the right peptide for the right indication, at the right dose, for the right patient, is what separates effective peptide therapy from expensive guesswork.

Tissue Repair and Injury Recovery

BPC-157 (Body Protection Compound-157)

BPC-157 is a 15-amino-acid peptide derived from a protective protein found in human gastric juice. It is the most widely discussed peptide in regenerative medicine, and its preclinical research profile is extensive. Animal studies and in-vitro research have demonstrated that BPC-157 accelerates the healing of muscle, tendon, ligament, and bone injuries through mechanisms that include promoting new blood vessel formation (angiogenesis), upregulating growth hormone receptor expression in damaged tissue, reducing inflammation, and modulating nitric oxide pathways involved in vascular repair. A systematic review published in 2025 examined 36 studies on BPC-157 spanning from 1993 to 2024 and found consistent evidence of improved healing outcomes across multiple musculoskeletal injury models in animals. The peptide has also shown protective effects on gastrointestinal tissue, liver, pancreas, and endothelial cells in preclinical settings.

What Estrogen Replacement Does

BPC-157 is a 15-amino-acid peptide derived from a protective protein found in human gastric juice. It is the most widely discussed peptide in regenerative medicine, and its preclinical research profile is extensive. Animal studies and in-vitro research have demonstrated that BPC-157 accelerates the healing of muscle, tendon, ligament, and bone injuries through mechanisms that include promoting new blood vessel formation (angiogenesis), upregulating growth hormone receptor expression in damaged tissue, reducing inflammation, and modulating nitric oxide pathways involved in vascular repair.

A systematic review published in 2025 examined 36 studies on BPC-157 spanning from 1993 to 2024 and found consistent evidence of improved healing outcomes across multiple musculoskeletal injury models in animals. The peptide has also shown protective effects on gastrointestinal tissue, liver, pancreas, and endothelial cells in preclinical settings.

The honest assessment: BPC-157 has an impressive preclinical track record, but robust human clinical trials are limited. It is not FDA-approved for any indication. Early human safety data from a small pilot study in 2025 reported short-term tolerability, but this does not establish efficacy or long-term safety. In clinical practice, BPC-157 is used by integrative and sports medicine providers for soft tissue injuries, joint pain, post-surgical recovery, and gut healing—and many patients report meaningful benefit. But it remains investigational, and anyone considering it should do so under proper medical supervision with appropriate informed consent.

TB-500 (Thymosin Beta-4 Fragment)

TB-500 is a synthetic fragment of thymosin beta-4, a naturally occurring peptide involved in tissue repair, cell migration, and wound healing. Where BPC-157 tends to work more locally at the site of injury, TB-500 is thought to have more systemic effects on healing and recovery. Preclinical research has shown that thymosin beta-4 promotes cell migration to injured areas, supports new blood vessel formation, reduces inflammation, and helps regulate the extracellular matrix involved in tissue remodeling.

In practice, TB-500 is often used alongside BPC-157 for musculoskeletal injuries, particularly when both local and systemic healing support are desired. Like BPC-157, TB-500 lacks FDA approval and has limited published human efficacy data, though the safety profile in preclinical models has generally been favorable.

Growth Hormone Optimization

CJC-1295 and Ipamorelin

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce and release growth hormone. Ipamorelin is a selective growth hormone secretagogue that works through a complementary pathway—it activates the ghrelin receptor to trigger growth hormone release without significantly raising cortisol, prolactin, or other pituitary hormones. This selectivity distinguishes ipamorelin from earlier secretagogues that had broader and less desirable hormonal effects.

These two peptides are frequently combined because they stimulate growth hormone through different receptor pathways, producing a synergistic effect: CJC-1295 provides sustained elevation of growth hormone and IGF-1 levels, while ipamorelin produces sharper, more physiologic growth hormone pulses. Human studies on CJC-1295 have demonstrated dose-dependent increases in growth hormone and IGF-1 that can persist for days after a single injection, with evidence of cumulative benefit with repeated dosing.

Growth hormone optimization through secretagogues like CJC-1295 and ipamorelin is clinically relevant because growth hormone plays critical roles in body composition, muscle maintenance, fat metabolism, tissue repair, bone density, sleep quality, and cellular regeneration—all of which decline significantly with age. Rather than replacing growth hormone directly (as with exogenous HGH), secretagogues stimulate your body’s own production, which preserves the natural pulsatile pattern of growth hormone release and generally carries a more favorable safety profile.

Common clinical applications include: improving body composition (increasing lean mass, reducing visceral fat), enhancing recovery from exercise and injury, improving sleep depth and quality, supporting skin and connective tissue health, and slowing age-related decline in physical performance and resilience.

Sermorelin

Sermorelin is a 29-amino-acid peptide that represents the biologically active portion of GHRH. It was the first GHRH analog used clinically and was FDA-approved for the treatment of growth hormone deficiency in children, though it was later withdrawn from the market for commercial—not safety—reasons. Sermorelin stimulates growth hormone release through the same GHRH receptor pathway as CJC-1295 but has a shorter half-life, requiring more frequent dosing. It is often prescribed as a nighttime injection to amplify the natural growth hormone pulse that occurs during deep sleep.

Body Composition and Metabolic Support

Several peptides used in clinical practice have direct or indirect effects on body composition and metabolic function—not through appetite suppression or stimulant effects, but through their influence on growth hormone, insulin sensitivity, fat oxidation, and lean tissue preservation.

Growth hormone secretagogues (CJC-1295, ipamorelin, sermorelin) support body composition by increasing growth hormone output, which promotes fat metabolism and lean muscle maintenance. Multiple studies have linked increased growth hormone circulation to improved muscle strength, reduced body fat, and better metabolic markers in adults—particularly in populations over 40 where age-related growth hormone decline is already contributing to unfavorable body composition changes.

AOD-9604, a modified fragment of human growth hormone, has been studied specifically for its fat-reducing properties. It was originally developed as an anti-obesity therapy and has shown the ability to stimulate fat breakdown (lipolysis) and inhibit the formation of new fat cells (lipogenesis) in preclinical and early clinical research. Unlike full-length growth hormone, AOD-9604 does not appear to affect blood sugar or promote cell proliferation, which gives it a distinct safety advantage for metabolic applications.

These peptides do not replace the need for proper nutrition, resistance training, and metabolic health management. They work best as part of a comprehensive protocol that addresses the hormonal, nutritional, and lifestyle factors driving body composition challenges—particularly after age 40 when multiple converging factors make fat loss harder and muscle preservation more critical.

Sleep and Recovery

Growth hormone is primarily released during deep (slow-wave) sleep, and its decline with age is one reason sleep quality deteriorates and recovery slows. Growth hormone secretagogues—particularly when dosed at bedtime—can enhance the natural nocturnal growth hormone pulse, which many patients report translates to deeper sleep, more restful nights, and improved recovery from both physical training and daily stress.

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide that has been studied for its effects on sleep architecture. Research has shown that DSIP promotes the transition to deeper sleep stages without the sedative hangover effects associated with pharmaceutical sleep aids. It has also been studied for its influence on stress resilience and cortisol regulation. While the clinical evidence base for DSIP is still developing, it represents a peptide-based approach to sleep that works with your body’s natural sleep mechanisms rather than overriding them.

Improved sleep has cascading benefits for every other system discussed in this article—hormone production, immune function, tissue repair, cognitive performance, and metabolic health all depend on adequate deep sleep. For patients whose sleep quality has declined with age, peptide therapy targeting sleep and growth hormone output can be one of the highest-leverage interventions available

Immune Function and Inflammation

The immune system relies on peptide signaling more than most people realize. Thymosin alpha-1, for example, is a naturally occurring peptide produced by the thymus gland that plays a central role in immune regulation. It enhances the function of T-cells (the immune system’s frontline defenders), promotes the maturation of dendritic cells (which coordinate the immune response), and modulates cytokine production to balance immune activity between underperformance and overreaction.

Thymosin alpha-1 has been studied in multiple randomized controlled trials for conditions including sepsis, chronic viral hepatitis, and immune support during chemotherapy. While it is not FDA-approved in the United States, it is approved and regulated for therapeutic use in over 35 countries for immune enhancement. It represents one of the more evidence-supported peptides in clinical use.

BPC-157 also demonstrates anti-inflammatory properties in preclinical models, reducing inflammatory markers and promoting resolution of inflammation in damaged tissue. For patients dealing with chronic low-grade inflammation—a common feature of aging, metabolic dysfunction, and autoimmune conditions—peptides that modulate rather than simply suppress the inflammatory response offer a more nuanced approach than conventional anti-inflammatory medications.

Gut Health and Gastrointestinal Repair

BPC-157’s origins in human gastric juice make it particularly relevant for gastrointestinal applications. Preclinical research has demonstrated protective and healing effects on the gut lining, including acceleration of ulcer healing, protection against NSAID-induced gastric damage, and promotion of intestinal anastomosis healing (reconnection of intestinal segments after surgery).

These properties make BPC-157 of interest for patients dealing with intestinal permeability (leaky gut), inflammatory bowel conditions, NSAID-related gut damage, and other gastrointestinal issues where mucosal repair is a clinical priority. While human trial data for these specific applications remain limited, the mechanism of action—promoting angiogenesis and tissue repair at the mucosal level—is consistent with the peptide’s broader healing profile observed across other tissue types.

Gut health has far-reaching implications for systemic health, influencing immune function, nutrient absorption, inflammation, and even mood and cognitive function through the gut-brain axis. Peptide support for gut repair is most effective when combined with dietary modification, targeted supplementation, and identification of the underlying drivers of gut dysfunction—whether that’s chronic stress, food sensitivities, dysbiosis, or medication-induced damage.

Cognitive Function and Neuroprotection

Several peptides under investigation show promise for cognitive support and neuroprotection, though this is one of the areas where the evidence is most preliminary.

Selank is a synthetic peptide based on the naturally occurring immunomodulatory peptide tuftsin. It has been studied in Russia for its anxiolytic (anxiety-reducing) and nootropic (cognition-enhancing) effects, with research suggesting it modulates serotonin and dopamine metabolism, reduces anxiety without sedation, and may support cognitive function under stress. Selank has regulatory approval in Russia but not in the United States.

Semax, another peptide developed in Russian neuroscience research, is a synthetic analog of ACTH(4-10) that has been studied for its effects on cognitive performance, memory, attention, and neuroprotection. Research has demonstrated effects on BDNF (brain-derived neurotrophic factor) expression, which plays a critical role in neuroplasticity and learning.

Dihexa is an investigational peptide that has shown remarkable potency in preclinical models for promoting neural connections, with research suggesting it may support the formation of new synapses. It is among the most experimental peptides discussed in this article and should be approached accordingly.

The cognitive and neuroprotective applications of peptide therapy are an active area of research. For patients interested in these applications, the priority should be ensuring that foundational drivers of cognitive decline—sleep quality, hormonal balance, metabolic health, inflammation, and nutrient status—are addressed first, with peptide support layered in as an adjunct under appropriate clinical guidance.

Sexual Health and Libido

PT-141 (bremelanotide) is a melanocortin receptor agonist that works centrally in the brain to enhance sexual desire. Unlike PDE5 inhibitors (such as sildenafil or tadalafil), which primarily address the vascular mechanics of erection, PT-141 targets the neurological pathways involved in arousal and desire itself. It is FDA-approved under the brand name Vylesi for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women—making it one of the few peptides with full FDA approval for a specific clinical indication.

PT-141 has also been studied in men for erectile dysfunction, particularly in cases where PDE5 inhibitors are ineffective or poorly tolerated, with research showing improvement in erectile response through its central mechanism of action. In clinical practice, PT-141 is used for both men and women experiencing low libido or sexual dysfunction, particularly when the issue is driven by desire rather than purely mechanical factors.

Sexual health is influenced by the entire hormonal, metabolic, and neurological landscape. PT-141 addresses the neurological component, but optimal outcomes typically require concurrent attention to hormone levels (testosterone, estrogen, progesterone), cardiovascular health, stress and cortisol management, sleep quality, and relationship factors.

What Peptide Therapy Does Not Do

Peptide therapy is a powerful set of tools, but it is not a shortcut, a cure-all, or a replacement for the foundational work of health optimization. Being direct about what peptides cannot do is essential to setting appropriate expectations.

Peptide therapy does not fix a broken foundation. If your nutrition is poor, your sleep is insufficient, your stress is unmanaged, and you are not resistance training, peptides will not overcome those deficits. They amplify and support biological processes—they do not create health from nothing.

Peptide therapy does not replace comprehensive evaluation. Using peptides without understanding your hormonal, metabolic, thyroid, and nutritional status is guesswork. The best outcomes come from identifying what your body actually needs and using peptides as targeted interventions within a broader clinical strategy.

Peptide therapy does not have a uniform evidence base. Some peptides—like PT-141 and thymosin alpha-1—have substantial human clinical data. Others—like BPC-157—have extensive preclinical evidence but limited human trials. Still others are highly experimental. Patients should understand where each peptide falls on the evidence spectrum and make informed decisions accordingly.

Peptide therapy does not eliminate the need for medical oversight. These are bioactive compounds that affect hormone signaling, immune function, tissue growth, and neurological pathways. They require proper dosing, appropriate cycling, monitoring for response and side effects, and coordination with your overall health management. Self-prescribing peptides purchased from unregulated online sources is not a responsible approach to health.

The Evidence Landscape: An Honest Assessment

One of the challenges of peptide therapy is that the evidence base is uneven. Some peptides have decades of human clinical research. Others have extensive animal data but minimal human trials. Still others are supported primarily by mechanistic studies and clinical observation.

Strong human evidence: PT-141 (FDA-approved for HSDD), thymosin alpha-1 (approved in 35+ countries, multiple RCTs), sermorelin (formerly FDA-approved for pediatric GH deficiency), CJC-1295 (randomized placebo-controlled human pharmacokinetic data showing sustained GH and IGF-1 elevation).

Strong preclinical evidence with growing clinical use: BPC-157 (36 studies across multiple tissue types, consistent healing effects, limited human safety data), TB-500 (preclinical tissue repair evidence, limited human data), ipamorelin (pharmacokinetic and selectivity data demonstrating GH release without cortisol or prolactin elevation).

Emerging or experimental: Selank, semax, dihexa, DSIP, and several other peptides with promising preclinical signals but limited or no published human clinical trials in Western medical literature.

A responsible peptide therapy provider will be transparent about where the evidence stands for each peptide they recommend and will help you weigh the potential benefits against the current state of the research. Peptide therapy done well is precise, informed, and honest about what is known and what is not.

Safety

Your safety comes first. Peptide therapy, when prescribed by a qualified physician, sourced from reputable compounding pharmacies using pharmaceutical-grade ingredients, and administered with proper protocols, is generally well-tolerated. However, peptides are bioactive compounds and carry risks that vary by the specific peptide, dose, route of administration, and individual patient factors. Key safety considerations include:

  • Source quality matters. Peptides obtained from unregulated online sources may contain impurities, incorrect concentrations, or contaminants. All peptides should be sourced from licensed compounding pharmacies that follow current good manufacturing practices.
  • Growth hormone secretagogues should not be used by individuals with active cancer or a recent history of cancer, as growth hormone can promote the proliferation of existing malignant cells. Screening for cancer history and appropriate ongoing monitoring is essential.
  • BPC-157’s angiogenic properties (promoting new blood vessel growth) are beneficial for tissue repair but raise theoretical concerns in the context of active malignancy, as tumors depend on angiogenesis for growth. This has not been demonstrated as a clinical risk, but it warrants caution and proper screening.
  • Injection site reactions (redness, swelling, mild discomfort) are the most common side effects across injectable peptides and are typically mild and self-limited.
  • Individual responses vary. What works well for one patient may produce different effects in another. Peptide therapy should be monitored with follow-up assessments and adjusted based on clinical response.

Seek urgent medical care if you experience chest pain, shortness of breath, severe headache, significant swelling or hives, dizziness, or signs of an allergic reaction during or after peptide administration. If you are currently taking medications for any condition, changes to your treatment plan should always be coordinated with your prescribing physician.

FAQs

What is peptide therapy good for?

Peptide therapy has clinically meaningful applications across tissue repair and injury recovery, growth hormone optimization, body composition and metabolic support, sleep quality and recovery, immune function and inflammation modulation, gut health, cognitive support, and sexual health. The specific benefits depend on which peptide is used, the individual’s health status and goals, and how the therapy is integrated into a broader clinical strategy. Peptide therapy is most effective when guided by comprehensive testing and individualized protocol design—not chosen from a menu.

Are peptides the same as steroids or HGH?

No. Peptides are fundamentally different from anabolic steroids and exogenous human growth hormone (HGH). Steroids are synthetic hormones that directly override your body’s endocrine system, often with significant side effects including suppression of natural hormone production. Exogenous HGH replaces growth hormone from an external source. Growth hormone secretagogue peptides like CJC-1295 and ipamorelin, by contrast, stimulate your body’s own pituitary gland to produce and release growth hormone in a more natural, pulsatile pattern. This generally carries a more favorable safety profile and preserves your body’s own regulatory mechanisms.

Is peptide therapy FDA-approved?

It depends on the peptide. PT-141 (bremelanotide) is FDA-approved for hypoactive sexual desire disorder in premenopausal women. Sermorelin was previously FDA-approved for pediatric growth hormone deficiency. However, most peptides used in integrative and integrative medicine—including BPC-157, CJC-1295, ipamorelin, and TB-500—are not FDA-approved for their commonly prescribed indications. They are used off-label or as investigational compounds, typically sourced from licensed compounding pharmacies. This is an important distinction to understand, and it is why proper medical oversight is essential.

How are peptides administered?

Most therapeutic peptides are administered via subcutaneous injection—a small needle injected just under the skin, similar to an insulin injection. This is generally painless and easy to learn. Some peptides are also available in oral, nasal, or topical formulations depending on the specific compound and the clinical application. Your provider will determine the most appropriate route based on the peptide’s pharmacokinetics and your individual needs.

How long does it take to see results from peptide therapy?

This varies by peptide and application. Some effects—like improved sleep quality from growth hormone secretagogues dosed at bedtime—can be noticeable within the first week or two. Body composition changes typically develop over 4 to 12 weeks of consistent use. Tissue repair benefits from BPC-157 or TB-500 may be evident within weeks depending on the severity and type of injury. Cognitive and immune benefits tend to develop more gradually. Peptide therapy is not an overnight solution—it works with your body’s own signaling and repair systems, which take time.

Are peptides safe?

When prescribed by a qualified physician, sourced from reputable compounding pharmacies, and used according to proper protocols, peptides have a generally favorable safety profile. Side effects are typically mild—most commonly injection site reactions. However, safety depends on the specific peptide, the dose, the individual’s health history, and the quality of the product. Growth hormone secretagogues should be avoided in patients with active cancer. Some peptides require specific screening before initiation. Self-prescribing peptides from unregulated online sources carries significant risks including contamination, incorrect dosing, and lack of medical monitoring.

Can peptide therapy help with weight loss?

Certain peptides can support body composition improvements as part of a comprehensive approach. Growth hormone secretagogues like CJC-1295 and ipamorelin promote fat metabolism and lean tissue preservation by increasing growth hormone output. AOD-9604 has been studied specifically for its fat-reducing properties. However, peptides are not a weight loss shortcut. They work best when combined with proper nutrition, resistance training, metabolic evaluation, and—when indicated—hormone optimization. If the underlying drivers of weight gain (insulin resistance, hormonal decline, thyroid dysfunction, chronic inflammation) are not addressed, peptides alone are unlikely to produce lasting results.

What is the difference between BPC-157 and TB-500?

Both are used for tissue repair, but they work through different mechanisms. BPC-157 promotes healing primarily through angiogenesis (new blood vessel formation), growth hormone receptor upregulation, and nitric oxide pathway modulation, and tends to work more locally at the site of injury or administration. TB-500 promotes healing through enhanced cell migration, extracellular matrix regulation, and anti-inflammatory effects, and is thought to have more systemic healing properties. In practice, they are often used together for musculoskeletal injuries to provide both localized and systemic repair support.

Do peptides need to be cycled?

Many peptide protocols include cycling—periods of use followed by periods off—to prevent receptor desensitization and maintain therapeutic efficacy. A common growth hormone secretagogue cycle, for example, might be three months on followed by one month off. The specific cycling protocol depends on the peptide, the clinical indication, and individual response. Your provider will design a protocol that includes appropriate cycling based on your situation.

Do you offer telehealth appointments?

Yes. We offer telehealth consultations for patients who prefer virtual visits or live outside South Carolina. Initial consultations, lab reviews, protocol design, and ongoing monitoring can all be managed via video appointments. For patients who require injectable peptides, prescriptions are sent to licensed compounding pharmacies that ship directly to you.

What happens in the discovery call?

The discovery call is a free, no-obligation conversation where we learn about your health history, current symptoms, and goals. We’ll discuss whether peptide therapy—as part of a comprehensive health optimization plan—is appropriate for your situation and answer any questions you have about testing, specific peptides, the assessment process, and what to expect. There’s no pressure—it’s simply an opportunity to see if we’re the right team to help you understand what your body needs and how to get there.

Sources & Citations

Maura Forte, MSN, FNP-BC
Maura Forte is a board-certified Family Nurse Practitioner and co-founder of Vita Forte Integrative Medicine. She specializes in integrative and regenerative medicine, helping patients restore hormonal balance, improve metabolic health, and enhance overall vitality

Areas Served

Vita Forte Integrative Medicine is located in Daniel Island, SC, and serves patients throughout the Greater South Carolina area as well as virtually in the greater New York area. These areas include but are not limited to Berkeley County, SC, Charleston County, SC, and the cities of Daniel Island, SC, Charleston, SC, Mount Pleasant, SC, North Charleston, SC, Summerville, SC, Goose Creek, SC, Hanahan, SC, and Isle of Palms, SC.

menuchevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram